Immunomedics already has a TROP2 class drug on the market – Trodelvy ... Trodelvy in metastatic non-small cell lung cancer. The head of AstraZeneca's Chinese operations has been placed under ...
The "Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's offering. Antibody drug conjugates ...
AstraZeneca plans ... where the drug was used in the adjuvant treatment of patients with Stage IB, II and IIIA non-small cell lung cancer patients with EGFR mutations. The trial was stopped ...